Dyadic International (DYAI) Prepaid Assets (2017 - 2026)
Dyadic International (DYAI) posted Prepaid Assets of $174238.0 for Q1 2026, down 20.46% sequentially from $219067.0 in Q4 2025, and down 17.37% YoY from $210867.0 in Q1 2025.
Dyadic International (DYAI) Prepaid Assets (2017 - 2026) Analysis & Trends
Dyadic International has reported Prepaid Assets for 10 years, with the latest figure at $174238.0 in Q1 2026.
- Quarterly Prepaid Assets fell 17.37% year-over-year to $174238.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $174238.0 (down 17.37% YoY) and the FY2025 annual result came in at $219067.0, up 86.34% from the prior year.
- Prepaid Assets fell to $174238.0 in Q1 2026 per DYAI's latest filing, from $219067.0 in the prior quarter.
- Over five years, Prepaid Assets peaked at $148.7 million in Q1 2022 and troughed at $80.0 in Q1 2023.
- A 5-year average of $8.9 million and a median of $174238.0 in 2026 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2022 and 2023: Prepaid Assets jumped 18271890.17% in 2022, then plunged 100.0% in 2023.
- Over 5 years, Prepaid Assets stood at $124273.0 in 2022, then surged by 163.75% to $327775.0 in 2023, then tumbled by 64.13% to $117560.0 in 2024, then surged by 86.34% to $219067.0 in 2025, then decreased by 20.46% to $174238.0 in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $174238.0, $219067.0, and $339943.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Dyadic International | 19.98 Mn | 19.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 174,238.00 |
| Dec 31, 2025 | 219,067.00 |
| Sep 30, 2025 | 339,943.00 |
| Jun 30, 2025 | 84,984.00 |
| Mar 31, 2025 | 210,867.00 |
| Dec 31, 2024 | 117,560.00 |
| Sep 30, 2024 | 374,209.00 |
| Jun 30, 2024 | 126,720.00 |
| Mar 31, 2024 | 242,131.00 |
| Dec 31, 2023 | 327,775.00 |
| Sep 30, 2023 | 335.00 |
| Jun 30, 2023 | 93,865.00 |
| Mar 31, 2023 | 80.00 |
| Dec 31, 2022 | 124,273.00 |
| Sep 30, 2022 | 448,208.00 |
| Jun 30, 2022 | 285.00 |
| Mar 31, 2022 | 148.73 Mn |
| Dec 31, 2021 | 3,279.00 |
| Sep 30, 2021 | 569,965.00 |
| Jun 30, 2021 | 100,888.00 |